163 related articles for article (PubMed ID: 114343)
1. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Moriondo P; Travaglini P; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
[TBL] [Abstract][Full Text] [Related]
3. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Barbarino A; de Marinis L; Menini E; Anile C; Maira G
Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
[TBL] [Abstract][Full Text] [Related]
4. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Jeske W
Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
[TBL] [Abstract][Full Text] [Related]
5. Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
Kamal TJ; Molitch ME
Am J Med Sci; 1992 Nov; 304(5):289-93. PubMed ID: 1332473
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and TSH responses to TRH, chlorpromazine and L-dopa in children with human growth hormone deficiency.
Okada Y; Onishi T; Tanaka K; Morimoto S; Tsuji M; Watanabe K; Okazaki A; Takeuchi T; Kumahara Y
Acta Endocrinol (Copenh); 1978 Jun; 88(2):217-26. PubMed ID: 96645
[TBL] [Abstract][Full Text] [Related]
7. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
[TBL] [Abstract][Full Text] [Related]
8. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
[TBL] [Abstract][Full Text] [Related]
9. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
Brismar K
Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
[TBL] [Abstract][Full Text] [Related]
10. The possible prognostic value of serum prolactin increment during pregnancy in hyperprolactinaemic patients.
Andersen AN; Starup J; Tabor A; Jensen HK; Westergaard JG
Acta Endocrinol (Copenh); 1983 Jan; 102(1):1-5. PubMed ID: 6823776
[TBL] [Abstract][Full Text] [Related]
11. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
[TBL] [Abstract][Full Text] [Related]
12. The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma.
Marrs RP; Bertolli SJ; Kletzky OA
Am J Obstet Gynecol; 1980 Nov; 138(6):620-5. PubMed ID: 6776812
[TBL] [Abstract][Full Text] [Related]
13. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
[TBL] [Abstract][Full Text] [Related]
15. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
[TBL] [Abstract][Full Text] [Related]
16. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
[TBL] [Abstract][Full Text] [Related]
17. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
18. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
19. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Ho KY; Smythe GA; Compton PJ; Lazarus L
Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
[TBL] [Abstract][Full Text] [Related]
20. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
Leblanc H; Yen SS
Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
